Full Text View
Tabular View
Study Results
Related Studies
Predictive Factors for Ovarian Stimulation Using a Fixed Daily Dose of 200 IU Recombinant FSH (Study 142003)(P05696) (Xpect)
This study has been completed.
Study NCT00778999   Information provided by Merck Sharp & Dohme Corp.

First Received on October 23, 2008.   Last Updated on May 6, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial